Summary sentence: MicroRNAs utilize multiple mechanisms to regulate CD163 expression and integrate well-characterized macrophage phenotypes and functional properties seen in active systemic juvenile idiopathic arthritis.
INTRODUCTION
innate immune cells and proinflammatory cytokines including IL-1 and IL-6. 1 As such, monocytes and macrophages are proposed to be key effector cells in SJIA. Children with active SJIA have increased circulating monocytes, and these cells display enhanced surface expression of numerous activation markers including the scavenger receptor CD163. 2 Children with SJIA are at high risk for macrophage activation syndrome (MAS), an episode of overwhelming inflammation characterized by proliferation of cytolytic T cells and hemophagocytic macrophages, and leading to a cytokine storm. 3 Interestingly, bone marrow biopsies of patients with MAS show markedly increased macrophage markers including CD163, 4 and serum levels of soluble CD163 (sCD163) were elevated in SJIA patients with both overt and subclinical MAS. 5, 6 CD163 is as an innate pattern recognition receptor exclusively expressed on myeloid cells. 7 This receptor functions as a hemoglobin scavenger receptor, binding and engulfing circulating hemoglobin (Hgb):haptoglobin (Hp) complexes. CD163 directly mediates some anti-inflammatory functions of monocytes and macrophages by inducing IL-10 and heme oxygenase-1 production after ligand binding. 8 Indeed, mice deficient in CD163 had enhanced mortality in mouse models of sepsis. 9 Monocyte expressed CD163 likely plays key functional roles during active SJIA and MAS as well. These patients have a pronounced erythropoiesis gene expression signature, associated with high red blood cell turnover and markedly elevated serum ferritin levels that can mediate oxidative injury. 10 There is also enhanced Hp production in SJIA, 10, 11 which functions together with CD163 to clear free Hgb, limiting tissue damage and triggering release of antiinflammatory compounds. Indeed, along with elevated levels of IL-10, serum HO-1 levels have been shown to be a highly specific marker for active SJIA. 12 CD163 also serves as a scavenger receptor for high mobility group box 1 (HMGB1), a damage-associated molecular pattern (DAMP) overexpressed in MAS which serves to amplify inflammatory responses. 13 Notably, along with CD163, macrophages in SJIA and MAS produce high levels of proinflammatory mediators including TNF , IL-6, and IL-18, 14, 15 and these cells are believed to have key roles in SJIA pathogenesis. 1 Taken together, CD163 expression on monocytes and macrophages mediates key anti-inflammatory responses and may serve to limit tissue damage and inflammation, particularly during MAS.
Activated monocytes and macrophages adopt distinct functional phenotypes based upon signals from their local environment, in a process known as polarization. These polarized populations elaborate effectors optimized for a variety of functions, including inflammation, tissue remodeling and repair, and immunoregulation. Although previously considered as a dichotomy between classically activated "M1" and alternatively activated "M2" macrophages, recent work has shown that macrophages can be activated toward a diverse spectrum of distinct phenotypes. 16 Expression of CD163 has largely been associated with several well-characterized in vitro conditions, and particularly induced by the anti-inflammatory cytokine IL-10 (M(IL- 10) or previously "M2c"). [17] [18] [19] [20] In contrast, other alternatively activated phenotypes such as those induced by LPS along with immune complexes (M(LPS+IC) or "M2b") produce both proinflammatory mediators including TNF , IL-1, and IL-6 along with immune regulatory properties and IL-10 production, but have lower CD163 expression. 21 How these activation states represent monocytes in inflammatory conditions such as SJIA is unclear. Importantly however, previous immunophenotyping and transcriptional profiling has demonstrated that monocytes in SJIA do not align with a single defined polarization state but rather exhibit features reflecting multiple activation phenotypes, including classical activation, M(IL-10) and M(LPS+IC). 2, 10, 22, 23 In agreement with this, effective macrophage polarization requires the integration of multiple cellular signaling pathways into coordinated changes in gene expression. As such, microRNAs have emerged as important epigenetic contributors to this process. MicroRNAs are small non-coding RNAs that serve as transcriptional negative regulators by directly binding to the 3 ′ untranslated region (UTR) of specific target transcripts to mediate mRNA degradation and/or inhibit translation. 24 MicroRNAs have been shown to play key roles in regulating gene expression programs involved in cell proliferation, differentiation, and inflammation, including monocyte and macrophage polarization. 25, 26 Our recent work found a broad spectrum of microRNAs with increased expression in monocytes from children with active systemic JIA. 27 We also found that one of these microRNAs, miR-125a-5p, functioned as a key regulator of M(LPS+IC) phenotypes, which resembles some of the features seen in SJIA monocytes. Mir-125a has also recently been shown to stabilize Treg-medicated immune homeostasis in mouse models of autoimmunity, but its functions in myeloid cells are incompletely understood. 28 Other microRNAs increased in active SJIA also have key roles in inflammation, including the miR-181 family, which can regulate macrophage cytokine gene expression. 29, 30 These findings suggest that microRNAs may function to coordinate and integrate polarization-associated gene expression programs essential to monocytes in active systemic JIA.
Here, we examined microRNA regulation of CD163 expression in activated monocytes and macrophages. We hypothesized that microRNAs function as key post-transcriptional regulators that integrate and balance polarized phenotypes in these cells during active SJIA, and in particular function as negative regulators of CD163. Indeed, we identify a network of microRNAs that restrict expression of CD163 during M(LPS+IC) activation, despite robust autologous IL-10 production. This inhibition is modulated through 2 distinct mechanisms-both direct targeting of CD163 mRNA and indirectly through global effects on cytokine receptor gene expression including the IL-10 receptor. MicroRNA expression also significantly reduced CD163-mediated anti-inflammatory properties of macrophages, supporting key roles for these epigenetic factors in maintaining functional polarization phenotypes during hyperinflammation.
MATERIALS AND METHODS

Cell isolation and culture
THP-1 monocytic cells were obtained from ATCC (Manassas, VA).
Isolation of CD14+ peripheral blood monocytes was as described. 27 Monocyte-derived macrophages (MDMs) were isolated from peripheral blood from healthy adult donors through the Cell Processing and Manipulation Core. Briefly, peripheral blood mononuclear cells were isolated by density gradient centrifugation through Ficoll-Paque Plus (GE Healthcare, Pittsburgh, PA), washed twice in RPMI and then placed in culture medium supplemented with 5 ng/mL monocyte colony stimulating factor (R&D Systems, Minneapolis, MN) at 2 × 10 6 cells/mL.
After 5-7 days of differentiation, cells were washed 3 times to remove non-adherent lymphocytes prior to cell stimulation.
Cell stimulation/polarization
All ligands were purchased from R&D Systems except for LPS, which was from Sigma-Aldrich (St. Louis, MO). Prior to stimulation, THP-1 cells were differentiated overnight after addition of 50 ng/mL phorbol myristate acetate (PMA). The cells were left untreated or stimulated with IL-10 (1-50 ng/mL), IFN (20 ng/mL), LPS (10-100 ng/mL), IL-4 (20 ng/mL), or TGF (0.5 ng/mL). IgG-coated wells were prepared as described. 26 
Flow cytometry
CD163 mRNA transcripts were detected in single cells using the PrimeFlow TM kit according to manufacturer's directions (Affymetrix, eBioscience, Santa Clara, CA). Briefly, THP-1 cells were stained for surface CD163 using anti-human CD163 (Trilium, Brewer, ME). The 
Gene expression
Cellular mRNA levels were quantified using real-time RT-PCR. Briefly, total RNA was isolated as described using Trizol and purity and concentration were determined using a NanoDrop ND-1000 spectrophotometer (Thermo Fisher). Approximately 1 g of RNA was used to synthesize cDNA using the iScript cDNA synthesis kit (BioRad, Hercules, CA). Real-time PCR was performed in 20 L reactions using Viia7 Realtime PCR Instrument with gene-specific primers and Fast SYBR Green Supermix (Life Technologies, Carlsbad, CA). Message copy numbers were normalized against the copy number of the housekeeping gene GAPDH as described. 31 Primers specific for GAPDH and CD163 were described previously. 27 Additional primers are as follows: TFGBR2 forward 5 ′ -GTAGCTCTGATGAGTGCAATGAC- 33 For quantification of microRNA levels, individual Taqman assays (Life Technologies) were performed using Bio-Rad iCycler thermocycler and a Viia7 Realtime PCR Instrument, calculated using the comparative C T method and normalized to RNU48.
MicroRNA antagomir and mimic and RNA interference
To knock-down microRNA expression, THP-1 cells were differentiated overnight as described above and then treated with 300 nM negative control or miR-125a-5p micrOFF antagoMIR (Ribobio, Guangzhou, China). To augment microRNA expression, THP-1 cells differentiated overnight with PMA were transfected with pre-miR microRNA precursors. Briefly, negative control pre-miR or miR-125a-5p (Dharmacon, Lafayette, CO) were incubated using RNAiMAX reagent using protocol described by Gantier et al., 34 with a final mimic concentration of 300 nM. Efficiency of microRNA inhibition or overexpression was determined using individual Taqman assays as described below. Similarly, IL10RA expression was inhibited using ON-TARGETplus siRNA SMARTpool (Dharmacon) transfected as above. Once transfection mixture was added to each well, cells were incubated at 37 • C in 5% CO 2 for 72 h. Dual-Luciferase Reporter Assay System (Promega) was used to evaluate the luciferase activity of each well according to the manufacturer's instruction using GloMax R Discover instrument (Promega).
RNA immunoprecipitation assay
Luciferase reporter system
Genome-wide microRNA target analysis
To identify potential microRNA target genes, miR-125a-5p mimic was overexpressed in THP-1 cells as described above. Extracted RNA was amplified using the NuGEN Ovation RNA-Seq System v2, after which the Nextera XT DNA Sample Preparation Kit was used to prepare DNA library templates. Libraries were then sequenced using the Illumina HiSeq2500, with approximately 35-40million reads per sample.
RNA-seq data analysis follows the protocol described in Anders et al. 35 Reads were aligned to the reference human genome (hg19) using the TopHat aligner. 36 Counts of the reads aligned to the coding region of each gene were summarized using ShortRead 37 and associated Bioconductor packages for manipulation and analysis of next-generation sequencing data. Statistical analysis to identify differentially expressed genes (DEGs) was performed based on a negative-binomial distribution of read counts as implemented by the edgeR Bioconductor package 38 using FDR adjusted P values. 39 Cluster analysis of genes and samples were performed using Bayesian infinite mixture model based clustering 40 
RESULTS
Expression of CD163 mRNA is specifically induced by M(IL-10) polarization and not by other polarized phenotypes
Although CD163 expression has been associated broadly with alternatively activated macrophages, the precise polarized phenotypes marked by CD163 are not fully understood. To define the in vitro conditions that induce CD163 expression in monocytes and macrophages, we used 2 distinct methods to quantify CD163 mRNA changes. First, CD163 mRNA levels were determined using quantitative RT-PCR in (Fig. 1A) . As an alternative approach to quantify CD163 in polarized macrophages, we used RNA flow cytometry with PrimeFlow.
This technique uses fluorescent in situ hybridization with oligonucleotide probe sets and signal amplification to obtain gene expression information. 44 These probes can also be combined with fluorescently- (Fig. 1B) . Recent studies have reported that more prolonged stimulation with M(LPS+IC) can induce CD163, possibly due to autocrine production of IL-10 in this condition. 16 However in our hands, prolonged stimulation with M(LPS+IC) for 48 or 72 h did not increase CD163 mRNA levels above that seen in untreated macrophages, despite continued robust IL-10 expression (Fig. 1C) . On the other hand, LPS has been shown to repress CD163 expression with as little as 6 h treatment. 45 Indeed, we found that polarization induced changes in CD163 mRNA levels occurred as early as 3 or 6 h, with significant increases in M(IL-10)-treated cells and decreases in M(LPS+IC)-treated cells (Fig. 1D) . Taken together, these findings demonstrate that CD163 mRNA expression is specifically induced only upon M(IL-10) polarization, repressed by M(LPS+IC) treatment, and minimally altered by other well-characterized polarizing conditions.
Increased expression of multiple microRNAs associated with SJIA can regulate CD163
MicroRNAs play key roles in integrating signal transduction pathways and serving to "fine-tune" gene expression programs in monocyte and macrophage polarization. As such, we hypothesize that monocyte microRNA elevated in active SJIA can regulate polarization phenotypes including CD163 expression. Our previous work demonstrated elevated miR-125a-5p in monocytes from children with active SJIA, and that miR-125a-5p levels correlated with clinical and laboratory features of systemic inflammation. 27 We also found that miR-125a-5p expression was specifically induced in conditions with This previous work also showed that 2 members of the miR-181 family, miR-181a and miR-181c, were up-regulated in active SJIA compared to patients in clinically inactive disease or healthy control children. 27 Porcine miR-181 family members have been shown to target monocyte CD163 to suppress viral infection 46 ; however, whether these microRNAs impact CD163 expression in humans is unknown. First, we found that miR-125a-5p, miR-181a, and miR181c are expressed in THP-1 cells (Fig. 2A) , as well as primary CD14+ monocytes and MDM (Supplemental Fig. 1 ). To determine whether these microRNAs can inhibit CD163 expression in human macrophages, THP-1 cells were transfected with mature microRNA mimics. Overexpression of either miR-125a-5p or miR-181c, but not miR-181a, significantly reduced levels of IL-10 induced CD163 mRNA compared to cells transfected with control mimic (Fig. 2B) . Taken together, these findings suggest that miR-125a-5p and miR-181c, upregulated in monocytes from children with SJIA, inhibit CD163 mRNA expression. (Fig. 2C) . Of note, M(LPS+IC) polarization significantly represses CD163 expression in monocytes and macrophages despite robust autocrine IL-10 production (Fig. 1) , which is the hallmark of this phenotype. 47 Indeed, we found that M(LPS+IC) treatment induces miR-125a-5p and miR-181c expression in as little as 6 h (Fig. 2D) , concomitant with the fall in CD163 mRNA expression under this same condition (Fig. 1D ). Given this, we hypothesized that miR-125a and miR-181 family members restrict CD163 expression under M(LPS+IC) conditions through a feedback loop.
Specific microRNA antagomirs were used to diminish intracellular microRNA levels during macrophage polarization (Supplemental Fig.   2 ). Of note, miR-181c antagomir also led to a slight but significant decrease in miR-181a expression (Supplemental Fig. 2C ). Treatment of THP-1 macrophages with miR-125a-5p antagomir markedly increased levels of CD163 mRNA after M(LPS+IC) polarization (Fig. 2E) . Inhibition of miR-181c also led to a smaller but significant increase in CD163 expression (Fig. 2E) . Taken together, these results show that up-regulation of miR-125a-5p and miR-181 family members limits induction of CD163 during M(LPS+IC).
Direct targeting of CD163 mRNA by miR-181 family members but not by miR-125a-5p
To date, functional analysis of microRNA targeting human CD163 for degradation in human macrophages has not been performed. To explore this, the microRNA target prediction program TargetScan 48 was used to identify putative microRNA:mRNA interactions. We identified a conserved miR-181 family binding site in the 3 ′ -UTR of CD163 (Fig. 3A) . Notably this site is among the best predicted by this algorithm, with a Context++ score of 91%. This is in agreement with previous findings that porcine miR-181 can target CD163, although the microRNA seed sequences are not fully conserved. 46 In contrast, miR-125a-5p was not predicted to bind CD163 by TargetScan or by MirDB, which uses a distinct machine learning model to predict microRNA:mRNA binding. 49 To validate this putative miR-181 binding experimentally, we first utilized an RNA immunoprecipitation assay, where total RNA delivered to the RISC for degradation are co-precipitated along with protein components. This method allows for direct examination of microRNAmediated targeting within the cell type of interest. Overexpression of miR-181c in THP-1 macrophages markedly enhanced the delivery of CD163 mRNA to the RISC, compared to overexpression of negative control RNA mimics (Fig. 3B) . As a complementary method to confirm the predicted CD163-miR-181 binding site, we utilized a luciferase reporter vector with the CD163 3 ′ -UTR cloned downstream of the Firefly luciferase gene. Co-transfection of this construct in 293T cells along with specific miR-181a or miR-181c mimics led to significantly reduced luciferase activity, compared to negative control RNA mimic (Fig. 3C) . In contrast, miR-125a-5p mimic did not significantly alter luciferase activity, further supporting the lack of a specific binding site for CD163. Finally, site-directed mutagenesis was used to alter the predicted miR-181 family binding site in the CD163 3 ′ -UTR to reduce specific binding (Fig. 3A) . Indeed, co-transfection of miR-181a or miR181c did not reduce luciferase activity using this mutant construct (Fig. 3C) . Together, these findings show that miR-181 family members directly bind to the CD163 3 ′ -UTR to target this mRNA for microRNAmediated degradation in macrophages.
Overexpression of miR-125a-5p induces global transcriptional changes impacting macrophage polarization
As shown above and in contrast to miR-181 family members, miR125a-5p does not appear to directly interact with CD163 mRNA. To determine how miR-125a-5p overexpression may impact macrophage phenotypes and affect CD163 expression, a genome-wide target analysis was performed. Total RNA was extracted from THP-1 cells overexpressing either negative control or miR-125a-5p mimic, and DEGs were determined by RNA-Seq. Correcting for multiple comparisons, this identified 28 DEGs, 21 with significantly decreased expression and 7 with increased expression upon miR-125a-5p mimic transfection (Table 1 and Fig. 4A ; FDR corrected P < 0.1). Analysis of repressed genes upon miR-125a-5p overexpression showed that 38% (8/21) were predicted targets of this microRNA (Table 1) . To identify broader gene networks targeted by miR-125a-5p, the wider samples of 291 DEG (Supplemental Table 1 ; uncorrected P < 0.01) was utilized to perform pathway analysis using Ingenuity. The most significantly enriched KEGG pathway represented by miR-125a-5p-repressed genes was "cytokine-cytokine receptor interactions" (Table 2 ; FDR-corrected P = 5.31E−16). Other highly enriched pathways included "TLR signaling pathway," "Jak-STAT signaling pathway," and "chemokine signaling pathway." Indeed, among the most significantly down-regulated genes identified were IL10RA, encoding IL-10 receptor subunit alpha, and TGFBR2, encoding TGF-beta receptor type-2 ( Table 1) . Repression of both genes upon miR-125a-5p overexpression was confirmed using specific qRT-PCR (Fig. 4B) . Using flow cytometry, we also showed that miR-125a-5p mimic overexpression decreased IL10RA protein levels compared to NC mimic (Fig. 4C ). Both gene products are receptors for key cytokines that mediate macrophage activation, and in the case of IL-10 is a potent inducer of CD163 mRNA expression. This supports a hypothesis that miR-125a-5p inhibits IL-10 induced CD163 expression through reducing levels of the IL10 receptor. Indeed, we
show that miR-125a-5p overexpression in macrophages was sufficient to markedly reduce signaling through the IL-10 receptor, as determined by IL-10 induced STAT3 phosphorylation (Fig. 4D) . To examine this further, macrophage IL10RA expression was suppressed using siRNA (Supplemental Fig. 2 ). When these macrophages were then stimulated with IL-10, there was a significant reduction in CD163 mRNA up-regulation compared to cells treated with scrambled siRNA (Fig. 4E) , confirming that IL10RA expression is essential for CD163 expression. Taken together, these findings suggest that miR-125a-5p is induced in M(LPS+IC) conditions to limit CD163 expression in response to autocrine IL-10 production, through inhibiting expression of key cytokine receptors.
MicroRNA expression alters CD163-mediated anti-inflammatory properties of macrophages
A major function of CD163 on monocytes and macrophages is clearance of potentially damaging endogenous products including free Hgb and HMGB1, which are elevated in active SJIA. CD163 binds to these DAMPs complexed with Hp, leading to their internalization and production of anti-inflammatory mediators including IL-10. We hypothesized that microRNA inhibiting CD163 expression would similarly impair the ability of macrophages to respond to these complexes. First, we confirm that stimulation with either Hgb-Hp and HMGB1-Hp complexes, but not Hgb or HMGB1 alone, trigger increased IL-10 production from THP-1 cells (Fig. 5A ). This production is CD163-dependent, as co-treatment with a CD163 blocking antibody significantly reduces this IL-10 production (Fig. 5A) . We also found that HMGB1-Hp complexes fail to induce pro-inflammatory cytokines including IL-1 , IL-6, IL-8, and IL-23 ( Supplemental Fig. 4) . THP-1 cells were then transfected with specific microRNA mimics to miR-181c. Compared to cells transfected with negative control mimics, miR-181c mimic-transfected (Fig. 5B) . The effects of miR-125a-5p mimic could not be tested as our previous work has shown that this treatment itself enhances IL-10 production. 27 These findings suggest that microRNA expression can regulate key CD163-dependent functional properties involved in limiting tissue damage during hyperinflammation as seen in SJIA and MAS.
DISCUSSION
CD163-expressing monocytes and macrophages are increasingly recognized as important myeloid effector cells in multiple autoimmune and autoinflammatory rheumatic disorders.
Macrophages with high CD163 levels can be detected in discoid lupus skin lesions 50 and in lupus nephritis. 51 In addition, secreted markers of M(IL-10) or "M2c" macrophages, including sCD163, were increased in adult 52 and juvenile-onset 53 systemic lupus erythematosus, and correlated with disease activity. 52 Patients with active SJIA demonstrate activation of blood monocytes with increased CD163 expression. 1 In addition, emergence of MAS in patients with SJIA is associated with hemophagocytic macrophages in tissues demonstrating markedly increased in production of both pro-inflammatory mediators such as TNF , IL-6, and IL-18, as well as sCD163 and surface CD163 expression. 4, 5, 14, 15 In turn, CD163-expressing monocytes and macrophages serve key roles during inflammation by clearing TA B L E 1 Significantly down-regulated genes with miR-125a overexpression, FDR < 0.1. Bold indicates predicted miR-125a-5p target genes 9 and sCD163 has suppressive effects on lymphocytes in vitro. 54 MicroRNAs are increasingly recognized as having key roles in regulating functional polarization of monocytes and macrophages. Here, we identify a network of microRNA in monocytes that are increased in SJIA and integrate polarization phenotypes, regulating both CD163 expression and anti-inflammatory functions (Fig. 6) . Members of the miR-181 family directly target CD163 transcripts for degradation. In contrast, miR-125a-5p functions indi- Indeed, several reports have highlighted altered circulating or cellular microRNA levels in SJIA. [55] [56] [57] Our previous monocyte microRNA expression profiling identified a broad spectrum of microRNA with altered expression in children with active SJIA. 27 Here, we find several of those microRNAs, miR-125a-5p and miR-181 family members, regulate both CD163 expression and key anti-inflammatory functions in monocytes and macrophages. Interestingly, these microRNAs are also induced specifically under M(LPS+IC) polarizing conditions, and function as a feedback loop to limit CD163 expression in this phenotype despite autologous IL-10 production. We show here that miR-181 family members regulate CD163 through direct targeting of this mRNA in human macrophages. It is unclear why in our hands in vitro, the miR-181c mimic reduces CD163 expression but the miR181a mimic does not (Fig. 2B ). This may be due to the higher baseline abundance of miR-181a in THP-1 cells, MDMs and primary monocytes (Supplemental Fig. 1) . In porcine macrophages, several members of the miR-181 family similarly regulate CD163 expression. 46 Previous work has suggested that miR-181 family members play key roles in monocytes and macrophages, by directly down-regulating proinflammatory cytokine genes including IL-1 and IL-6, and promoting endotoxin tolerance. 29, 30 MiR-181a also affects key transcription factors including C/EBP to modulate functional properties of polarized macrophages. 58 In marked contrast, we demonstrate here that miR-125a-5p regulates CD163 not through direct targeting but through induction of global changes in macrophage gene expression. We show that the most significantly enriched gene pathway upon miR-125a-5p overexpression was "cytokine-cytokine receptor interactions," specifically reducing expression of IL10RA, which is required to induce CD163 expression in response to IL-10. We also found significantly reduced expression of TGFBR2. Notably, TGF has been previously reported to induce macrophage CD163 expression, 59 although we observed minimal induction in our hands (Fig. 1) . These findings are in agreement with emerging evidence that miR-125a has broad roles in promoting immunoregulatory phenotypes in both myeloid and lymphoid cells.
We and others have found that miR-125a inhibits antimicrobial functions and promotes alternative macrophage polarization in human and murine cells. 27, 60, 61 Recent work has also found that miR-125a-5p has key roles in T regulatory cells by decreasing sensitivity to inflammatory cytokines such as IL-6 and stabilizing immune homeostasis. 28, 62 Although the precise transcriptional targets for miR-125a in human macrophages remain unclear, our data support this regulator having genome-wide effects on the ability of macrophages to respond to cytokines and other polarizing conditions. CD163 is both a marker of activated monocytes and macrophages and serves key functional roles during inflammation. 9 It is an anti- However, this is unlikely to occur through direct activation, as CD163
is not among the early STAT3-dependent genes induced by IL-10, 17 and the CD163 promoter was also not identified in a genome-wide analysis of STAT3 binding in macrophages. 66 However, several studies show that CD163 expression in monocytes and macrophages involves integration and cross-talk between multiple cytokine signaling pathways. 17, 65, 67 It is increasingly clear that monocyte and macrophage polarization is not a dichotomy between classical M1 and alternative M2 activation, but rather a spectrum of phenotypes optimized for particular environments and inflammatory states. 16, 45, 68, 69 Although there is strong evidence that monocytes are key effector cells in SJIA, [70] [71] [72] our studies begin to characterize how those states are regulated and integrated to lead to the phenotype seen in active disease. Both transcriptional profiling of PBMCs and direct monocyte immunophenotyping in SJIA patients demonstrates features of multiple well characterized in vitro conditions. 2, 10, 22, 23 This includes increased CD163 expression, further enhanced during MAS, with higher levels of sCD163 and strikingly high surface expression on macrophages in tissue. [4] [5] [6] Here we find that miR-125a and miR-181 family members, which are elevated in active SJIA, are induced in M(LPS+IC) conditions and serve to limit CD163 expression in the setting of high autologous IL-10 production.
Of note, M(LPS+IC) has key similarities to that seen in SJIA, including increased expression of TNF , IL-1, IL-6, and IL-10. 27 In contrast, CD163 expression is associated with distinct polarizing conditions, most notably M(IL-10), which lacks expression of these microRNA.
This supports a hypothesis where the monocyte phenotype in the hyperinflammatory environment of active SJIA represents a mixed phenotype including features resembling M(LPS+IC) and M(IL-10), with microRNA including miR-125a and miR-181 "fine-tuning" that mixture (Fig. 6) . Indeed, further increases in CD163 expression associated with MAS may signal that the mixed phenotype has been altered, and monocyte and macrophage functions have been drastically changed. This hypothesis is further supported by recent findings by us and others that emergence of MAS is associated with high circulating levels of IFN-and IFN-induced chemokines. 73, 74 These mediators are associated with classical monocyte and macrophage activation and were significantly higher than those seen in patients with SJIA without MAS. Indeed, IFN-has been shown to reduce the accumulation of numerous microRNAs in macrophages including miR-125-5p. 75 Further study is needed to characterize the regulation of monocytes and macrophages in SJIA and MAS, and the role of key functions such as CD163 in disease pathogenesis. AUTHORSHIP N.S., S.T., A.A.G., and G.S.S. conceived the study, designed the experiments, and/or gave technical support and conceptual advice. T.D., R.T., and G.S.S. performed the experiments. M.B. and M.M. performed RNAseq data analysis. S.T., A.A.G., and G.S.S. analyzed the data. G.S.S. wrote the first draft of the manuscript. All authors commented on and contributed to the final draft of the manuscript.
